Key Insights Lonza Group's estimated fair value is CHF412 based on 2 Stage Free Cash Flow to Equity Lonza Group ...
Crinetics Pharmaceuticals (CRNX) is back in focus after completing a US$350.139 million follow on equity offering, closely ...
A good number of them showcased prototypes that may or may not ever reach the market. Below, we highlight the nine most ...
In the intricate world of modern plumbing and HVAC systems, where efficiency and precision are paramount, Yuyao Kangtai Pipe Technology Co., Ltd. has solidified its position as a leading global ...